Further considerations on adverse reactions to radiopharmaceuticals

被引：15
作者：
Salvatori, Massimo [1 ]
Treglia, Giorgio [1 ]
Mores, Nadia [2 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Nucl Med, Policlin Univ A Gemelli, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Inst Pharmacol, Policlin Univ A Gemelli, I-00168 Rome, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 08期
关键词：
NUCLEAR-MEDICINE; PREVALENCE;
D O I：
10.1007/s00259-012-2120-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1360 / 1362
页数：3
相关论文
共 10 条
  • [1] Adverse events in nuclear medicine - cause for concern?
    Hesse, B.
    Vinberg, N.
    Berthelsen, A. K.
    Ballinger, J. R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (05) : 782 - 785
  • [2] Hesslewood SR, 1997, EUR J NUCL MED, V24, P1179
  • [3] European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000
    Hesslewood, SR
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (05) : BP13 - BP19
  • [4] Kusakabe Kiyoko, 2006, Kaku Igaku, V43, P23
  • [5] Kusakabe Kiyoko, 2008, Kaku Igaku, V45, P19
  • [6] Kusakabe Kiyoko, 2007, Kaku Igaku, V44, P29
  • [7] Matsuda Hiroshi, 2009, Kaku Igaku, V46, P29
  • [8] Pitfalls With Radiopharmaceuticals
    Santos-Oliveira, Ralph
    Machado, Marcio
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 342 (01) : 50 - 53
  • [9] Silberstein EB, 1996, J NUCL MED, V37, P185
  • [10] Silberstein EB, 1998, J NUCL MED, V39, P2190
1